ENO1 and hepatocellular carcinoma: Yu et al. demonstrated that lncRNA-6195 is part of a complex containing ENO1, inhibiting ENO1’s enzymatic activity, glucose consumption, and lactate abundance in hepatocellular carcinoma (HCC).